IFNG and hepatocellular carcinoma: In the context of mouse tumor models, NR4A1 (Nuclear Receptor 4A1) has emerged as a significant player, mediating NK-cell dysfunction in hepatocellular carcinoma through the IFNγ/p-STAT1/IRF1 pathway [56].